Predicting drug resistance.
Where this comes from
- Record sourced from PubMed, PMID 39503728.
- Also identified by DOI 10.7554/eLife.103775 and PMC identifier 11540300.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.
Medical subject headings
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Drug Resistance, Neoplasm